Navigation Links
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Date:11/24/2008

Combination to Create a Leading Specialty Pharmaceutical Company with Greater Commercialization Capabilities, Expanded Portfolio of Pain Management Products and a Strengthened Pipeline

King Extends Tender Offer Through December 19, 2008

BRISTOL, Tenn. and BRIDGEWATER, N.J., Nov. 24 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. (NYSE: KG) and Alpharma Inc. (NYSE: ALO) today announced that the two companies have signed a definitive merger agreement under which King will acquire all of the outstanding shares of Class A Common Stock of Alpharma for $37.00 per share in cash for a total equity value of approximately $1.6 billion. The Boards of Directors of both companies have unanimously approved the transaction.

Under the terms of the merger agreement, King's tender offer for all of the outstanding shares of Class A Common Stock of Alpharma, which was scheduled to expire at 5:00 p.m., New York City time, on Friday, November 21, 2008, will be extended and will remain open through 5:00 p.m., New York City time, on Friday, December 19, 2008, unless further extended in accordance with the merger agreement. The terms and conditions of King's amended offer will be described in amended offer documents, which will be filed with the Securities and Exchange Commission ("SEC") and mailed to Alpharma stockholders. Alpharma's Board recommends that Alpharma stockholders tender their shares into King's amended offer.

As of the close of business on November 21, 2008, by King's estimate, approximately 30,713,179 shares of Class A Common Stock of Alpharma (including approximately 1,963,583 shares subject to guarantees of delivery), representing approximately 73% of all outstanding shares, were validly
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
6. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
7. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
8. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
10. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
11. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... (PRWEB) September 16, 2014 Founded by ... Party PAC is a political organization fighting to legalize ... on Amendment 2, The After Party recently commissioned a ... that I Want” from the movie “Grease.” ( http://youtu.be/zdcvhUgeDRg ... (Yes on 2)” the musical parody faithfully recreates the ...
(Date:9/16/2014)... York (PRWEB) September 16, 2014 ... HTTP Live Streaming (HLS) & UStream API’S to serve ... a wonderful feature for broadcasting live video events with ... Android apps. , The App Builder is known for ... like android, iOS, BlackBerry and Windows 8 and already ...
(Date:9/16/2014)... 16, 2014 Whatisfinalexpenseinsurance.com has released a ... finding affordable life insurance for seniors. , Finding affordable ... faster. A big part of the insurance market has ... important tips that clients can use when shopping for ... senior is important for providing financial security for vulnerable ...
(Date:9/16/2014)... San Francisco, September 15, 2014Prostate cancer patients who ... their quality of life, as well as bladder ... and after RT, according to research presented today ... 56th Annual Meeting. Additionally, results indicate that parallel ... patients who receive different regimens of HPFX RT. ...
(Date:9/16/2014)... who have had children (parous women) appear to ... breast cancer, the subtype that carries a higher ... of African ancestry. A similar relationship was ... between childbearing and increased risk of estrogen receptor-negative ... the women who had never breastfed. These findings, ...
Breaking Medicine News(10 mins):Health News:Miami Beach Politician Drives 1,400 Miles to Texas to Shoot “Grease” Parody Video Supporting the Legalization of Medical Marijuana in Florida 2Health News:Life Insurance for Seniors - Clients Can Find Fast Life Insurance By Comparing Online Quotes! 2Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 2Health News:Prostate cancer patients who receive hypofractionated RT report consistent QoL 3Health News:Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk 2
... emergency departments with pneumonia, they are likely to be ... dying over the next year, despite the more aggressive ... University of Pittsburgh that will be presented at the ... Tuesday, May 20. Even when social and environmental factors ...
... to suffer symptoms, but trained counselors could help , , ... lung transplant patients are four to five times more ... disorder (PTSD) than the average person, researchers report. , ... Society,s 2008 International Conference in Toronto on May 19, ...
... ATS 2008, TORONTOSymptoms of depression and post-traumatic stress ... patients are four-to-five times more prevalent than in ... the stress levels of caregivers, as well as ... dying and death. Their findings were presented at ...
... conscious businesses of the 21st century? Why not Bentley graduates? ... businesses that transform the world? Maybe that,s what your heart is ... calling out to you to do." -- John ... address,to approximately 1,000 Bentley undergraduate students at the 89th,commencement ceremony on ...
... poster session presented today by The University of Texas ... Society 33rd Annual Congress, found that early nursing intervention ... decrease in the incidence of lymphedema, better management of ... cancer patients. , The literature review, led by ...
... Education Campaign on Behalf of CSL Behring, maker of Zemaira(R), ... ... Therapy, KING OF PRUSSIA, Pa., May 17 Melissa Biggs, a ... education campaign on behalf of CSL Behring, and is,urging Americans to get ...
Cached Medicine News:Health News:Gender disparity in community-acquired pneumonia 2Health News:Depression, PTSD Common Among Lung Transplant Patient Caregivers 2Health News:Depression and PTSD symptoms in caregivers of lung transplant patients 2Health News:John Mackey, Chairman and CEO of Whole Foods Market(R), and Ellen M. Zane, President and CEO, Tufts Medical Center and the Floating Hospital for Children, Offer Advice to Bentley Students at May 17 Commencement 2Health News:John Mackey, Chairman and CEO of Whole Foods Market(R), and Ellen M. Zane, President and CEO, Tufts Medical Center and the Floating Hospital for Children, Offer Advice to Bentley Students at May 17 Commencement 3Health News:John Mackey, Chairman and CEO of Whole Foods Market(R), and Ellen M. Zane, President and CEO, Tufts Medical Center and the Floating Hospital for Children, Offer Advice to Bentley Students at May 17 Commencement 4Health News:John Mackey, Chairman and CEO of Whole Foods Market(R), and Ellen M. Zane, President and CEO, Tufts Medical Center and the Floating Hospital for Children, Offer Advice to Bentley Students at May 17 Commencement 5Health News:John Mackey, Chairman and CEO of Whole Foods Market(R), and Ellen M. Zane, President and CEO, Tufts Medical Center and the Floating Hospital for Children, Offer Advice to Bentley Students at May 17 Commencement 6Health News:M. D. Anderson nurse addresses lymphedema in breast cancer patients and survivors 2Health News:M. D. Anderson nurse addresses lymphedema in breast cancer patients and survivors 3Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 2Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 3Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 4Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 5
(Date:9/16/2014)... BETHESDA, Md. , Sept. 16, 2014 ... a biotechnology company developing DCVax® personalized immune therapies for ... the first product to receive formal designation as a ... to Medicines Scheme" (EAMS) launched in the UK in ... a 2-step process for early access approval under the ...
(Date:9/16/2014)... Sept. 16, 2014 Imprimis Pharmaceuticals, Inc. (Nasdaq: ... to delivering high quality and novel medicines to physicians ... Executive Officer Mark Baum will be a ... Select Conference in New York City.  Mr. Baum will ... Dropless™ campaign in ophthalmology. The presentation is scheduled for ...
(Date:9/16/2014)... 2014 Henry Schein, Inc. (NASDAQ: ... health care products and services to office-based dental, ... Stanley M. Bergman, Henry Schein,s Chairman of the Board and ... services panel at the Leerink Partners Services Roundtable on Tuesday, ... Dr. Stohler, Dean of Columbia University,s College of ...
Breaking Medicine Technology:NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Henry Schein To Present At The Leerink Partners Services Roundtable 2
... System is a rapid, real-time thermal cycler ... samples. By automating much of the testing ... programmable, it is the fastest, easiest to ... the market. The SmartCycler delivers highly accurate ...
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
... The LightCycler 2.0 System is the ... Applied Science. This new instrument offers six ... 530, 560, 610, 640, 670, and 710nm. ... cooling by air and working with glass ...
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
Medicine Products: